Researchers discover how malignant melanoma eludes immune cells

by Alan Dove,Columbia University Irving Medical CenterCredit:Cancer Cell(2023). DOI: 10.1016/j.ccell.2023.05.014Malignant melanoma, a dangerous type of skin cancer, deploys an elegan

Updated on: February 03,2024

Researchers discover how malignant melanoma eludes immune cells

by Alan Dove,Columbia University Irving Medical CenterCredit:Cancer Cell(2023). DOI: 10.1016/j.ccell.2023.05.014Malignant melanoma, a dangerous type of skin cancer, deploys an elegan

Updated on:February 03,2024

Researchers develop novel approach for predicting resistance against cancer therapy

by National University of SingaporeMultispectral microscopy with quantitative immunofluorescence is a state-of-the-art technology that can detect oncogenes simultaneously, allowing for the identi

Updated on: February 18,2024

Researchers develop novel approach for predicting resistance against cancer therapy

by National University of SingaporeMultispectral microscopy with quantitative immunofluorescence is a state-of-the-art technology that can detect oncogenes simultaneously, allowing for the identi

Updated on:February 18,2024

Researchers identify immune cell that helps kill bladder cancer tumors

by The Mount Sinai HospitalMyeloid immune cells alongsidered blood cells in an electron micrograph of human blood. Credit: National Cancer InstituteMount Sinai researchers have made two imp

Updated on: February 18,2024

Researchers identify immune cell that helps kill bladder cancer tumors

by The Mount Sinai HospitalMyeloid immune cells alongsidered blood cells in an electron micrograph of human blood. Credit: National Cancer InstituteMount Sinai researchers have made two imp

Updated on:February 18,2024

Study reports blocking key enzyme boosts anti-cancer T-cell responses and resistance to immunosuppression

byLouisiana State UniversityCredit:Frontiers in ImmunologyDOI: 10.3389/fimmu.2022.987298A study led by LSU Health New Orleans cancer researchers describes a novel therapeutic strateg

Updated on: January 16,2024

Study reports blocking key enzyme boosts anti-cancer T-cell responses and resistance to immunosuppression

byLouisiana State UniversityCredit:Frontiers in ImmunologyDOI: 10.3389/fimmu.2022.987298A study led by LSU Health New Orleans cancer researchers describes a novel therapeutic strateg

Updated on:January 16,2024

New molecular blocker halts breast cancer metastasis, says study

byBar-Ilan UniversityA cell-permeable peptide derived from the second proline-rich region of Pyk2 blocks spontaneous lung metastasis in an immune-competent xenograft mouse model. Credit:On

Updated on: January 16,2024

New molecular blocker halts breast cancer metastasis, says study

byBar-Ilan UniversityA cell-permeable peptide derived from the second proline-rich region of Pyk2 blocks spontaneous lung metastasis in an immune-competent xenograft mouse model. Credit:On

Updated on:January 16,2024

Lung cancer screening more cost effective when using risk model-based strategies, study shows

byUniversity of Texas M. D. Anderson Cancer CenterCredit: Pixabay/CC0 Public DomainRisk model-based lung cancer screening strategies, which select individuals based on personal risk, are more co

Updated on: January 16,2024

Lung cancer screening more cost effective when using risk model-based strategies, study shows

byUniversity of Texas M. D. Anderson Cancer CenterCredit: Pixabay/CC0 Public DomainRisk model-based lung cancer screening strategies, which select individuals based on personal risk, are more co

Updated on:January 16,2024

Shortage of vital children's cancer drug stirs fear and outrage

by Marie McCulloughCredit: CC0 Public DomainA critical shortage of a chemotherapy used to treat most childhood cancers has galvanized oncologists and parents of sick children.The U.S.medical com

Updated on: April 07,2024

Shortage of vital children's cancer drug stirs fear and outrage

by Marie McCulloughCredit: CC0 Public DomainA critical shortage of a chemotherapy used to treat most childhood cancers has galvanized oncologists and parents of sick children.The U.S.medical com

Updated on:April 07,2024

Researchers exploit DNA amplification in cancer to halt chemoresistance

by Stony Brook UniversityGábor Balázsi, in his Biomedical Engineering laboratory with Rafal Krzysztoń, PhD, and Yiming Wan, PhD, both first co-authors on thePNASpaper. Credit: John Gr

Updated on: June 08,2024

Researchers exploit DNA amplification in cancer to halt chemoresistance

by Stony Brook UniversityGábor Balázsi, in his Biomedical Engineering laboratory with Rafal Krzysztoń, PhD, and Yiming Wan, PhD, both first co-authors on thePNASpaper. Credit: John Gr

Updated on:June 08,2024

Active surveillance feasible for small, low-grade bladder cancer

(HealthDay)—For patients who present with small, low-grade pTa/pT1a recurrent papillary bladder tumors, active surveillance appears to be a reasonable strategy, according to a study published in the F

Updated on: April 07,2024

Active surveillance feasible for small, low-grade bladder cancer

(HealthDay)—For patients who present with small, low-grade pTa/pT1a recurrent papillary bladder tumors, active surveillance appears to be a reasonable strategy, according to a study published in the F

Updated on:April 07,2024

Research identifies a new drug candidate to starve and suffocate breast cancer cell stem growth

by University of SalfordMichael P. Lisanti. Credit: University of SalfordScientists have identified a new drug candidate that is able starve and suffocate cancer stem cells, paving the way for ne

Updated on: June 28,2024

Research identifies a new drug candidate to starve and suffocate breast cancer cell stem growth

by University of SalfordMichael P. Lisanti. Credit: University of SalfordScientists have identified a new drug candidate that is able starve and suffocate cancer stem cells, paving the way for ne

Updated on:June 28,2024

The protein behind immunotherapy resistance

byEcole Polytechnique Federale de LausanneTumor with FMRP-deficient cancer cells (in green) being infiltrated and attached by killer (CD8) T cells. Credit: Jeremy Guillot (Hanahan Lab – EPFL).Im

Updated on: January 02,2024

The protein behind immunotherapy resistance

byEcole Polytechnique Federale de LausanneTumor with FMRP-deficient cancer cells (in green) being infiltrated and attached by killer (CD8) T cells. Credit: Jeremy Guillot (Hanahan Lab – EPFL).Im

Updated on:January 02,2024

Researchers identify potential biomarker to distinguish two aggressive types of brain tumors in children

by Johns Hopkins University School of MedicineSMYD3 overexpression activates the EGFR pathway in CHLA01 cells. (A) Localization of endogenous SMYD3. Representative 60x Z-stack confocal images sho

Updated on: January 30,2024

Researchers identify potential biomarker to distinguish two aggressive types of brain tumors in children

by Johns Hopkins University School of MedicineSMYD3 overexpression activates the EGFR pathway in CHLA01 cells. (A) Localization of endogenous SMYD3. Representative 60x Z-stack confocal images sho

Updated on:January 30,2024